Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (46) 46
Conference Proceeding (7) 7
Newspaper Article (7) 7
Patent (6) 6
Book / eBook (5) 5
Publication (5) 5
Book Chapter (4) 4
Book Review (2) 2
Dissertation (1) 1
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
humans (13) 13
cancer (9) 9
animals (7) 7
diagnosis (7) 7
identification (7) 7
research (7) 7
calculating (6) 6
cell line, tumor (6) 6
computing (6) 6
counting (6) 6
electric digital data processing (6) 6
healthcare informatics, i.e. information and communicationtechnology [ict] specially adapted for the handling orprocessing of medical or healthcare data (6) 6
human necessities (6) 6
hygiene (6) 6
information and communication technology [ict] specially adaptedfor specific application fields (6) 6
medical or veterinary science (6) 6
oncology (6) 6
physics (6) 6
surgery (6) 6
analysis (5) 5
abridged index medicus (4) 4
article (4) 4
care and treatment (4) 4
cell biology (4) 4
expression (4) 4
female (4) 4
handling record carriers (4) 4
health aspects (4) 4
male (4) 4
mice (4) 4
presentation of data (4) 4
recognition of data (4) 4
record carriers (4) 4
research article (4) 4
tumors (4) 4
angiogenesis (3) 3
carcinoma, renal cell (3) 3
carcinoma, renal cell - pathology (3) 3
cell proliferation - drug effects (3) 3
endothelial growth-factor (3) 3
geomorphic indices (3) 3
geosciences, multidisciplinary (3) 3
growth (3) 3
hypoxia (3) 3
kidney neoplasms - pathology (3) 3
management (3) 3
metastasis (3) 3
molecular biology (3) 3
multidisciplinary sciences (3) 3
proteins (3) 3
renal cell carcinoma (3) 3
science (3) 3
urology & nephrology (3) 3
xenograft model antitumor assays (3) 3
adenocarcinoma - drug therapy (2) 2
adult (2) 2
aged (2) 2
anesthesiology (2) 2
angiotensin (2) 2
angiotensin i - pharmacology (2) 2
angiotensin- (2) 2
angiotensin‐ (2) 2
antineoplastic agents - pharmacology (2) 2
apoptosis (2) 2
asymmetry (2) 2
biology and life sciences (2) 2
breast (2) 2
carbon dioxide - blood (2) 2
carcinoma, renal cell - mortality (2) 2
cells (2) 2
chemical properties (2) 2
chromosomes (2) 2
clear cell-type renal cell carcinoma (2) 2
cooling (2) 2
delivery of health care (2) 2
disparities (2) 2
drainage-basin (2) 2
endocrinology & metabolism (2) 2
endothelium (2) 2
environmental sciences (2) 2
evolution (2) 2
gene expression regulation, neoplastic (2) 2
general tagging of cross-sectional technologies spanning over several sections of the ipc (2) 2
general tagging of new technological developments (2) 2
genetic aspects (2) 2
genetic-basis (2) 2
genetics (2) 2
histology (2) 2
hypertension (2) 2
hypoxia-inducible factor 1, alpha subunit - metabolism (2) 2
image data processing or generation, in general (2) 2
india (2) 2
kidney cancer (2) 2
kidney neoplasms - genetics (2) 2
kidney neoplasms - mortality (2) 2
maps (2) 2
medical research (2) 2
medicine (2) 2
medicine, research & experimental (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text River and basin morphometric indexes to detect tectonic activity: a case study of selected river basins in the South Indian Granulite Terrain (SIGT)
by Vijith, H and Prasannakumar, V and Sharath Mohan, M. A and Ninu Krishnan, M. V and Pratheesh, P
Physical Geography, ISSN 0272-3646, 07/2017, Volume 38, Issue 4, pp. 360 - 378
The effects and influence of tectonic processes on the Anjarakandy, Thalassery, Mahe, and Kuttiyadi watersheds and rivers of the South Indian Granulite Terrain... 
geomorphic indices | watershed | spatial heterogeneity | Tectonic influence | BHAVANI SHEAR ZONE | NEOTECTONIC ACTIVITY | STREAM | DEFORMATION | GEOMORPHIC INDEXES | KERALA | ENVIRONMENTAL SCIENCES | GEOGRAPHY, PHYSICAL | GEOSCIENCES, MULTIDISCIPLINARY | DRAINAGE-BASIN | INFERENCES | EVOLUTION | LONG PROFILES | METEOROLOGY & ATMOSPHERIC SCIENCES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text VM power metering: Feasibility and challenges
by Krishnan, Bhavani and Amur, Hrishikesh and Gavrilovska, Ada and Schwan, Karsten
Performance Evaluation Review, ISSN 0163-5999, 12/2010, Volume 38, Issue 3, pp. 56 - 60
Conference Proceeding
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Angiotensin‐(1‐7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt‐1
by Krishnan, Bhavani and Torti, Frank M and Gallagher, Patricia E and Tallant, E. Ann
The Prostate, ISSN 0270-4137, 01/2013, Volume 73, Issue 1, pp. 60 - 70
BACKGROUND Prostate cancer is the most frequently diagnosed malignancy and the second-leading cause of cancer death in men. The purpose of this study was to... 
placental growth factor | prostate cancer | sFlt‐1 | VEGF receptors | angiogenesis | vascular endothelial growth factor | angiotensin‐(1‐7) | sFlt-1 | angiotensin-(1-7) | SYSTEM | METASTASIS | II RECEPTOR BLOCKER | INHIBITS GROWTH | CELL-GROWTH | TUMOR ANGIOGENESIS | BREAST-CANCER | VEGF-TRAP | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | ENDOTHELIAL GROWTH-FACTOR | CONVERTING-ENZYME | Prostatic Neoplasms - blood supply | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Adenocarcinoma - pathology | Humans | Male | Peptide Fragments - pharmacology | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Pregnancy Proteins - metabolism | Vascular Endothelial Growth Factor A - metabolism | Adenocarcinoma - drug therapy | Adenocarcinoma - blood supply | Xenograft Model Antitumor Assays | Adenocarcinoma - metabolism | Animals | Mice, Nude | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Placenta Growth Factor | Angiotensin I - pharmacology | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Mice | Prostatic Neoplasms - drug therapy | Hypertension | Immunohistochemistry | Care and treatment | Chorionic gonadotropin | Oncology, Experimental | Research | Endothelium | Analysis | Angiotensin | Universities and colleges | Cholecystokinin | Vascular endothelial growth factor | Prostate cancer | Phosphotransferases | Tumors | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Abstract 2749: Effects of subtype specific chemotherapeutic immunomodulation in bladder cancer
by Kardos, Jordan and Bixby, Lisa and Truong, Andrew and Krishnan, Bhavani and Stewart, Kyle and Vincent, Benjamin and Kim, William
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 2749 - 2749
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Matching insurance claims data with EMR molecular status data in non-small cell lung cancer (NSCLC) patients: Understanding real-world molecular testing and prevalence rates at the site and investigator level
by Cushion, Michael Gregory and Krishnan, Bhavani and Hodge, Jeff Paul and Balusu, Jaya Chandra and Wagner, Joseph and Oliva, Cristina and Edwards, Dana
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e20568 - e20568
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Angiotensin‐(1‐7) attenuates metastatic prostate cancer and reduces osteoclastogenesis
by Krishnan, Bhavani and Smith, Thomas L and Dubey, Purnima and Zapadka, Michael E and Torti, Frank M and Willingham, Mark C and Tallant, E. Ann and Gallagher, Patricia E
The Prostate, ISSN 0270-4137, 01/2013, Volume 73, Issue 1, pp. 71 - 82
BACKGROUND Angiotensin-(1-7) [Ang-(1-7)] is an endogenous, heptapeptide hormone with anti-proliferative and anti-angiogenic properties. The primary objective... 
angiotensin‐(1‐7) | vascular endothelial growth factor | osteoclasts | metastatic prostate cancer | angiotensin-(1-7) | COLONY-STIMULATING FACTOR | ANGIOGENESIS | ADENOCARCINOMA | PATHOGENESIS | MICROENVIRONMENT | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | BONE METASTASIS | DIFFERENTIATION | EXPRESSION | FACTOR CONTRIBUTES | ENDOTHELIAL GROWTH-FACTOR | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Peptide Fragments - pharmacology | Vascular Endothelial Growth Factor A - metabolism | Neoplasm Metastasis - drug therapy | Bone Marrow Cells - drug effects | Angiotensin I - pharmacology | Antineoplastic Agents - pharmacology | Bone Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Osteoclasts - pathology | Bone Marrow Cells - pathology | Mice, SCID | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | Mice | Osteoclasts - drug effects | Hypertension | Medical colleges | Oncology, Experimental | Angiotensin | Research | Hormones | Metastasis | Vascular endothelial growth factor | Prostate cancer | Histochemistry | Cancer | Endothelium | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
by Ricketts, Christopher J and De Cubas, Aguirre A and Fan, Cheng and Fan, Huihui and Smith, Christof C and Smith, Jennifer and Lang, James and Lang, Martin and Reznik, Ed and Bowlby, Reanne and Gibb, Ewan A and Akbani, Rehan and Beroukhim, Rameen and Bottaro, Donald P and Choueiri, Toni K and Gibbs, Richard A and Godwin, Andrew K and Godwin, Eryn M and Haake, Scott and Hakimi, A. Ari and Henske, Elizabeth P and Hsieh, James J and Ho, Thai and Ho, Thai H and Kanchi, Rupa S and Krishnan, Bhavani and Kwiatkowski, David J and Lui, Wembin and Merino, Maria J and Mills, Gordon B and Myers, Jerome and Nickerson, Michael L and Reuter, Victor E and Reuter, Victor and Schmidt, Laura S and Schmidt, Heather K and Shelley, C. Simon and Shelley, Carl Simon and Shen, Hui and Shuch, Brian and Signoretti, Sabina and Srinivasan, Ramaprasad and Tamboli, Pheroze and Thomas, George and Vincent, Benjamin G and Vocke, Cathy D and Wheeler, David A and Yang, Lixing and Yang, Ian and Yang, Ju Dong and Yang, Hannah and Yang, Liming and Kim, Jaegil and Kim, William Y and Robertson, A. Gordon and Caesar-Johnson, Samantha J and Demchok, John A and Felau, Ina and Kasapi, Melpomeni and Ferguson, Martin L and Hutter, Carolyn M and Sofia, Heidi J and Tarnuzzer, Roy and Wang, Timothy and Wang, Linghua and Wang, Jioajiao and Wang, Min and Wang, Zhining and Wang, Jing and Zenklusen, Jean C and Zhang, Hailei and Zhang, Jiashan (Julia) and Zhang, Wei and Zhang, Hongxin and Zhang, Lizhi and Zhang, Jiexin and Zhang, Hongzheng and Chudamani, Sudha and Liu, Wenbin and Liu, Jia and Liu, Yuexin and Liu, Xiuping and Lolla, Laxmi and Naresh, Rashi and Pihl, Todd and Sun, Qiang and Sun, Yichao and Wan, Yunhu and Wu, Ye and Cho, Juok and DeFreitas, Timothy and Frazer, Scott and Gehlenborg, Nils and Getz, Gad and Heiman, David I and Lawrence, Michael S and Lin, Pei and Meier, Sam and Noble, Michael S and Saksena, Gordon and ... and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
Cell Reports, ISSN 2211-1247, 04/2018, Volume 23, Issue 1, pp. 313 - 326.e5
Renal cell carcinoma (RCC) is not a single disease, but several histologically defined cancers with different genetic drivers, clinical courses, and... 
clear cell renal cell carcinoma | papillary renal cell carcinoma | chromophobe renal cell carcinoma | CDKN2A | PanCanAtlas | immune signature | chromatin remodeling | DNA hypermethylation | TCGA | GENETIC-BASIS | MESSENGER-RNA | RNA-SEQ | DNA | SOMATIC POINT MUTATIONS | SEQUENCING DATA | CLASS DISCOVERY | EXPRESSION | KIDNEY CANCER | BREAST | CELL BIOLOGY | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma
by Bailey, Sean T and Smith, Aleisha M and Kardos, Jordan and Wobker, Sara E and Wilson, Harper L and Krishnan, Bhavani and Saito, Ryoichi and Lee, Hyo Jin and Zhang, Jing and Eaton, Samuel C and Williams, Lindsay A and Manocha, Ujjawal and Peters, Dorien J and Pan, Xinchao and Carroll, Thomas J and Felsher, Dean W and Walter, Vonn and Zhang, Qing and Parker, Joel S and Yeh, Jen Jen and Moffitt, Richard A and Leung, Janet Y and Kim, William Y
Nature Communications, ISSN 2041-1723, 06/2017, Volume 8, Issue 1, pp. 15770 - 15770
Renal carcinoma is a common and aggressive malignancy whose histopathogenesis is incompletely understood and that is largely resistant to cytotoxic... 
LYSYL OXIDASE | CONDITIONAL INACTIVATION | TARGETED INACTIVATION | TUMOR SUPPRESSION | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | C-MYC | GENE-EXPRESSION | VASCULAR TUMORS | CANCER | CYST DEVELOPMENT | Kidney Neoplasms - genetics | Carcinoma, Renal Cell - pathology | Humans | Gene Expression Regulation, Neoplastic | Carcinoma, Renal Cell - genetics | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Mice, Transgenic | Genes, myc | Kidney Neoplasms - mortality | Mice, Knockout | Xenograft Model Antitumor Assays | Carcinoma, Renal Cell - mortality | Animals | Cell Line, Tumor | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Kidney Neoplasms - pathology | Von Hippel-Lindau Tumor Suppressor Protein - genetics | ADP-Ribosylation Factors - metabolism | ADP-Ribosylation Factors - genetics | Von Hippel-Lindau Tumor Suppressor Protein - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
by Linehan, W. Marston and Spellman, Paul T and Ricketts, Christopher J and Creighton, Chad J and Fei, Suzanne S and Davis, Caleb and Wheeler, David A and Murray, Bradley A and Schmidt, Laura and Vocke, Cathy D and Peto, Myron and Al Mamun, Abu Amar M and Shinbrot, Eve and Sethi, Anurag and Brooks, Samira and Rathmell, W. Kimryn and Brooks, Angela N and Hoadley, Katherine A and Robertson, A. Gordon and Brooks, Denise and Bowlby, Reanne and Sadeghi, Sara and Shen, Hui and Weisenberger, Daniel J and Bootwalla, Moiz and Baylin, Stephen B and Laird, Peter W and Cherniack, Andrew D and Saksena, Gordon and Haake, Scott and Li, Jun and Liang, Han and Lu, Yiling and Mills, Gordon B and Akbani, Rehan and Leiserson, Mark D.M and Raphael, Benjamin J and Anur, Pavana and Bottaro, Donald and Albiges, Laurence and Barnabas, Nandita and Choueiri, Toni K and Czerniak, Bogdan and Godwin, Andrew K and Hakimi, A. Ari and Ho, Thai H and Hsieh, James and Ittmann, Michael and Kim, William Y and Krishnan, Bhavani and Merino, Maria J and Shaw, Kenna R. Mills and Reuter, Victor E and Reznik, Ed and Shelley, Carl S and Shuch, Brian and Signoretti, Sabina and Srinivasan, Ramaprasad and Tamboli, Pheroze and Thomas, George and Tickoo, Satish and Burnett, Kenneth and Crain, Daniel and Gardner, Johanna and Lau, Kevin and Mallery, David and Morris, Scott and Paulauskis, Joseph D and Penny, Robert J and Shelton, Candace and Shelton, W. Troy and Sherman, Mark and Thompson, Eric and Yena, Peggy and Avedon, Melissa T and Bowen, Jay and Gastier-Foster, Julie M and Gerken, Mark and Leraas, Kristen M and Lichtenberg, Tara M and Ramirez, Nilsa C and Santos, Tracie and Wise, Lisa and Zmuda, Erik and Demchok, John A and Felau, Ina and Hutter, Carolyn M and Sheth, Margi and Sofia, Heidi J and Tarnuzzer, Roy and Wang, Zhining and Yang, Liming and Zenklusen, Jean C and Zhang, Jiashan and Ayala, Brenda and Baboud, Julien and Chudamani, Sudha and Liu, Jia and Lolla, Laxmi and Naresh, Rashi and ... and The Cancer Genome Atlas Research Network and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
The New England Journal of Medicine, ISSN 0028-4793, 01/2016, Volume 374, Issue 2, pp. 135 - 145
Papillary renal-cell carcinomas account for 15 to 20% of kidney cancers. Type 1, which is often multifocal and more indolent, was associated with mutations in... 
FUMARATE | MEDICINE, GENERAL & INTERNAL | MET PROTOONCOGENE | GENETIC-BASIS | GERMLINE | HEREDITARY | NRF2 | PHENOTYPE | MUTATIONS | EXPRESSION | KIDNEY CANCER | Proto-Oncogene Proteins c-met - metabolism | RNA, Neoplasm - chemistry | Carcinoma, Papillary - genetics | Kidney Neoplasms - genetics | Humans | Kidney Neoplasms - metabolism | CpG Islands - physiology | Carcinoma, Papillary - metabolism | Proto-Oncogene Proteins c-met - genetics | DNA Methylation | Phenotype | Sequence Analysis, RNA | NF-E2-Related Factor 2 - metabolism | NF-E2-Related Factor 2 - genetics | RNA, Messenger - chemistry | Signal Transduction - physiology | Mutation | Proto-Oncogene Proteins c-met - chemistry | MicroRNAs - chemistry | Care and treatment | Histology | Carcinoma, Renal cell | Research | Gene mutations | Analysis | Phenotypes | Carcinoma | Cell survival | MiRNA | mRNA | Genomes | Antioxidants | Fumarate hydratase | Kidney cancer | DNA methylation | Molecular biology | Methylation | Chromosomes | Clear cell-type renal cell carcinoma | DNA sequencing | CpG islands | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Measurement of the effect of Isha Yoga on cardiac autonomic nervous system using short-term heart rate variability
by Muralikrishnan, Krishnan and Balakrishnan, Bhavani and Balasubramanian, Kabali and Visnegarawla, Fehmida
Journal of Ayurveda and Integrative Medicine, ISSN 0975-9476, 04/2012, Volume 3, Issue 2, pp. 91 - 96
Beneficial effects of Yoga have been postulated to be due to modulation of the autonomic nervous system. To assess the effect of Isha Yoga practices on... 
heart rate variability | Cardiovascular ANS | Isha Yoga | Measurement | Usage | Care and treatment | Heart beat | Electrocardiogram | Electrocardiography | Physiological aspects | Yoga | Diagnosis | Research | Cardiovascular diseases | Health aspects | Heart rate | Nervous system | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text mTOR inhibition induces compensatory, therapeutically targetable MEK activation in renal cell carcinoma
by Bailey, Sean T and Zhou, Bing and Damrauer, Jeffrey S and Krishnan, Bhavani and Wilson, Harper L and Smith, Aleisha M and Li, Mingqing and Yeh, Jen Jen and Kim, William Y
PLoS ONE, ISSN 1932-6203, 2014, Volume 9, Issue 9, pp. e104413 - e104413
Rapamycin derivatives allosterically targeting mTOR are currently FDA approved to treat advanced renal cell carcinoma (RCC), and catalytic inhibitors of... 
MAMMALIAN TARGET | RAPAMYCIN | PATHWAYS | SURVIVAL | IN-VIVO ACTIVITY | PI3K/AKT/MTOR | PHOSPHORYLATION | MULTIDISCIPLINARY SCIENCES | GROWTH | SUPPRESSION | COMBINED PI3K/MTOR | TOR Serine-Threonine Kinases - metabolism | Apoptosis - drug effects | Humans | Extracellular Signal-Regulated MAP Kinases - metabolism | Mechanistic Target of Rapamycin Complex 2 | Molecular Targeted Therapy | Mechanistic Target of Rapamycin Complex 1 | TOR Serine-Threonine Kinases - antagonists & inhibitors | Mitogen-Activated Protein Kinase Kinases - metabolism | Multiprotein Complexes - metabolism | Biocatalysis - drug effects | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Carcinoma, Renal Cell - enzymology | Phosphorylation - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Von Hippel-Lindau Tumor Suppressor Protein - metabolism | Allosteric Regulation - drug effects | Carcinoma, Renal Cell - pathology | Enzyme Activation - drug effects | Animals | Signal Transduction - drug effects | Kidney Neoplasms - enzymology | Cell Line, Tumor | Kidney Neoplasms - pathology | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Health aspects | Genetic engineering | Carcinoma, Renal cell | TOR protein | Crosstalk | Clinical trials | Activation | Kinases | Autophagy | Subgroups | Proteins | Cell activation | Allosteric properties | Pathways | Genetics | Catalysis | Inhibition | Growth factors | Medical research | Effectiveness | Extracellular signal-regulated kinase | Pharmacology | Rapamycin | 1-Phosphatidylinositol 3-kinase | Signaling | Hypoxia | Solid tumors | Clear cell-type renal cell carcinoma | Cancer | Tumors | Apoptosis | Kidney transplantation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights